Methods of treatment using specific binding agents of human...

Details Methods of treatment using specific binding agents of human... Methods of treatment using specific binding agents of human...

2006-08-04

2010-02-23

Gupta, Anish (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S013800, C530S326000

Reexamination Certificate

active

07666832

ABSTRACT:
Disclosed are peptides that bind to Ang-2. Also disclosed are peptibodies comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.

REFERENCES:
patent: 5116964 (1992-05-01), Capon et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5447860 (1995-09-01), Ziegler
patent: 5455165 (1995-10-01), Capon et al.
patent: 5514582 (1996-05-01), Capon et al.
patent: 5521073 (1996-05-01), Davis et al.
patent: 5643755 (1997-07-01), Davis et al.
patent: 5650490 (1997-07-01), Davis et al.
patent: 5814464 (1998-09-01), Davis et al.
patent: 5854202 (1998-12-01), Dedhar et al.
patent: 5879672 (1999-03-01), Davis et al.
patent: 5955291 (1999-09-01), Alitalo et al.
patent: 5972338 (1999-10-01), Godowski et al.
patent: 6030831 (2000-02-01), Godowski et al.
patent: 6166185 (2000-12-01), Davis et al.
patent: 6291646 (2001-09-01), Sledziewski et al.
patent: 6323323 (2001-11-01), Sledziewski et al.
patent: 6455035 (2002-09-01), Suri et al.
patent: 2003/0229023 (2003-12-01), Oliner et al.
patent: 2003/0236193 (2003-12-01), Oliner et al.
patent: WO-95/13387 (1995-05-01), None
patent: WO-95/21866 (1995-08-01), None
patent: WO-96/31598 (1996-10-01), None
patent: WO-98/05779 (1998-02-01), None
patent: WO-99/33865 (1999-07-01), None
patent: WO-99/43801 (1999-09-01), None
patent: WO-00/06195 (2000-02-01), None
patent: WO-00/23082 (2000-04-01), None
patent: WO-00/24782 (2000-05-01), None
patent: WO-00/57901 (2000-10-01), None
patent: WO-00/75323 (2000-12-01), None
patent: WO-00/77037 (2000-12-01), None
patent: WO-01/62891 (2001-08-01), None
patent: WO-01/71042 (2001-09-01), None
patent: WO-03/030833 (2003-04-01), None
patent: WO-03/057134 (2003-07-01), None
Carmeliet et al., “Angiogenesis in cancer and other diseases,”Nature, 407 (6801):249-257 (2000).
Chao et al., Genomic Sequence forArabidopsis thalianaBAC F1 K23 from Chromosome 1. Acc. No. Q9SHQe, EMBL/GenBank/DDBJ database, EMBL; AC007508, AAF 24543, Accessed Dec. 10, 2003.
Connell et al., Ashley Publications Ltd. ISSN 1354-3776, pp. 1171-1203 (2001).
Coxon et al. “Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis,” Arthritis Rheum. 46:2604-2612 (2002).
Feige et al., “Anti-interleukin-1 and anti-tumor necrosis factor-x synergistically inhibit adjuvant arthritis in Lewis rats,”Cell Mol. Life Sci. 57:1457-1470 (2000).
Lin Pengnian et al., “Inhibition of tumor angiogensis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth”.J. Clin. Invest. 100(8):2072-2078 (1997).
Oliner et al., “Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2,”Cancer Cell, 6(5):507-516 (2004).
Peacock et al., “A novel angiogenesis inhibitor suppresses rat adjuvant arthritis,”Cell Immunol. 160: 178-184 (1995).
Peacock et al., “Angiogenesis inhibition suppresses collagen arthritis,”J. Exp. Med. 175:1135-1138 (1995).
Putaporntip et al., “Diversity in the Thrombospondin-related Adhesive Protein Gene,”Gene, 268:97-104 (2001).
Siemeister, et al., “Two independent mechanisms essential for tumor angiogensis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the tie-2 pathway,”Cancer Research, 59(13): 3185-3191 (1999).
Syed et al., “The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colan cancer,”Cancer Research, 61:1255-1259 (2001).
Walsh et al., “Angiogenesis in the pathogenesis of inflammatory joint and lung diseases,”Arthritis Res. 3:147-153 (2001).

Affiliated with

Also associated with

Rating

Methods of treatment using specific binding agents of human... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treatment using specific binding agents of human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment using specific binding agents of human... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4201385